Three years ago, we finalized our first CRISPR patent landscape analysis, at that time combined with an analysis of the TALE patent landscape which was then significantly larger. There were only 90 CRISPR patent families in this early analysis… that is less than the whole set of new CRISPR patent publications in the past single month: 116 additional patent families in our latest CRISPR patent analytics data set.
In June 2017, representatives of the Broad Institute and MIT in front of the European Patent Office requested another extension of six months to answer the multiple oppositions to one of their granted patents EP2764103, due to the complexity of the case and links with other co-pending patent oppositions such as EP2771468. The latter will be examined in oral proceedings mid January 2018 – keep this milestone in mind whenever assessing the European CRISPR patent battle status!
A few weeks ago, the Doudna-Charpentier patent also received its grant notification in China. China confirms its significant patenting activity in our latest statistics, yet a number of those patent applications have not been extended internationally; we observe that the patent landscape in China is thus quite specific, compared to its European and US counterparts.
We are currently compiling statistics on granted CRISPR patents specifically, as this set is fast growing too. Stay tuned!
You can order online your copy of our 2017 CRISPR patent analytics report including database access to our classified CRISPR patent landscape data so you can browse and focus on the specifics of your technology and application interests. You may also subscribe to our monthly classified CRISPR patent data updates to stay tuned with the latest developments in this fast evolving, complex technology landscape. Contact us for a video demo of the database functionality!